NCT04421105View on ClinicalTrials.gov

A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 29, 2015

Primary Completion Date

October 30, 2015

Study Completion Date

November 5, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Lysergic acid diethylamide (LSD) 5µg

DRUG

Lysergic acid diethylamide (LSD) 10µg

DRUG

Lysergic acid diethylamide (LSD)20 µg

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Eleusis Therapeutics

INDUSTRY

NCT04421105 - A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years | Biotech Hunter | Biotech Hunter